Latest News & Events

Procarta CEO attends the Berlin CMR Conference 2019

Procarta Biosystems Ltd. attended the Berlin Novel Antimicrobials and AMR Diagnostics Conference…

Read more

PROCARTA ANNOUNCES €1.5 MILLION INVESTMENT FOR NEW CLASS OF ANTIBIOTICS TO COMBAT ANTIMICROBIAL RESISTANCE

Press Release - Stevenage, UK, 5th March, 2019 – Procarta Biosystems, a…

Read more

"Antibiotic resistance plan to fight 'urgent' global threat"

BBC News report on British Government plans to combat antimicrobial resistance.

https://www.bbc.co.uk/news/health-46973641

Read more

Procarta at BioSeed Life Science Investment Event

CEO of Procarta Biosystems Ltd. Dr. Andrew Lightfoot attended the BioSeed Early…

Read more

Procarta Biosystems Ltd speak at BioInfect 2018

Procarta's Chief Scientific Officer, Professor Michael McArthur, was invited to speak at…

Read more

NOW HIRING - Post-doctoral and Research Technician positions  

Two positions are available to join a laboratory developing novel oligonucleotide antimicrobials,…

Read more

Procarta Biosystems Ltd attend BioEurope, Copenhagen.

Dr Andrew Lightfoot (CEO) and Dr Martin Stocks (COO) attended BioEurope 24…

Read more

Global concern over antimicrobial resistance

A compelling report on the fight against antimicrobial resistance and its history.

BBC…

Read more

Procarta receives Seed investment of £600K

Procarta is pleased to announce it has completed the seed funding round…

Read more

Appointment of Andrew Lightfoot as Procarta CEO

Procarta has appointed Dr. Andrew Lightfoot as CEO to define and execute…

Read more